RecruitingPhase 2NCT07276360

Hypofractionated Radiotherapy for the Treatment of Locally Advanced Cervical Cancer in Uganda

Studying Adenocarcinoma of the cervix uteri

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Uganda Cancer Institute
Principal Investigator
Solomon Kibudde, MBChB, MMed.
Uganda Cancer Institute
Intervention
Hypofractionated Radiation Therapy(radiation)
Enrollment
278 enrolled
Eligibility
18 years · FEMALE
Timeline
2026 – 2029

Study locations (1)

Collaborators

Varian Medical Systems · Fogarty International Center of the National Institute of Health

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07276360 on ClinicalTrials.gov

Other trials for Adenocarcinoma of the cervix uteri

Additional recruiting or active studies for the same condition.

See all trials for Adenocarcinoma of the cervix uteri →

← Back to all trials